Hotline update of clinical trials and registries presented at the German Cardiac Society Meeting 2009

L S Maier1, S H Schirmer, K Walenta

  • 1Abt. Kardiologie & Pneumologie/Herzzentrum, Georg-August-Universität Göttingen, Göttingen, Germany.

Insights

This review highlights novel clinical trials and registries in cardiovascular medicine, presenting recent diagnostic and therapeutic developments. Leading experts shared key findings from the German Cardiac Society meeting, offering valuable insights for medical professionals.

Area of Science:

  • Cardiovascular Medicine
  • Clinical Trials
  • Medical Registries

Background:

  • The 75th annual meeting of the German Cardiac Society convened in April 2009.
  • Cardiovascular medicine is a rapidly evolving field with continuous advancements.

Purpose of the Study:

  • To provide an overview of novel clinical trials and registries in cardiovascular medicine.
  • To report key presentations from leading experts at the German Cardiac Society meeting.
  • To summarize recent diagnostic and therapeutic developments in the field.

Main Methods:

  • Review article format.
  • Compilation of data presented by experts involved in clinical trials and registries.
  • Synthesis of information from the 75th annual meeting of the German Cardiac Society.

Main Results:

  • Presentation of novel findings from ongoing and recently completed clinical trials.
  • Summary of data from various cardiovascular registries.
  • Insights into the latest diagnostic tools and therapeutic strategies.

Conclusions:

  • The review offers a comprehensive summary of current advancements in cardiovascular medicine.
  • Readers gain access to the most recent data on diagnostic and therapeutic developments.
  • The findings are relevant for clinicians and researchers in the field of cardiology.

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...